Karst, Matthias

Analgesic Effect of the Synthetic Cannabinoid CT-3 on Chronic Neuropathic Pain: A Randomized Controlled Trial

Karst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L., & Schneider, U. (2003) · JAMA

Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments

Cited by 340

The IASP classification of chronic pain for ICD-11: functioning properties of chronic pain

Nugraha, B., Gutenbrunner, C., Barke, A., Karst, M., Schiller, J., Schäfer, P., Falter, S., Korwisi, B., Rief, W., Treede, R.-D., et al. (2019) · Pain

Musculoskeletal pain and rehabilitationPain Management and Treatment

Cited by 153

Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H. (2012) · Drug Testing and Analysis

Cannabis and Cannabinoid ResearchPosttraumatic Stress Disorder Research

Cited by 117

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series

Karst, M., Halpern, J. H., Bernateck, M., & Passie, T. (2010) · Cephalalgia

Migraine and Headache StudiesPsychedelics and Drug Studies

Cited by 106

Pain measurements and side effect profile of the novel cannabinoid ajulemic acid

Salim, K., Schneider, U., Burstein, S., Hoy, L., & Karst, M. (2005) · Neuropharmacology

Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments

Cited by 58

Response to Tfelt-Hansen P: Is BOL-148 hallucinogenic?

Karst, M., Halpern, J., Bernateck, M., & Passie, T. (2011) · Cephalalgia

Migraine and Headache StudiesHallucinations in medical conditions

Cited by 4